The choice of control means that a US or European approval for Ambrx's ARX788 ma...
The American Cancer Society (ACS) and the American Society of Clinical Oncology ...
At the ASCO annual meeting, Tagrisso showed an improvement in progression free s...
QRL-204 is designed to restore UNC13A function, a gene identified as a risk fact...
GRIT has formed a strategic partnership with Quangang Pharmaceutical (Quangang) ...
The European Commission will now decide whether to grant marketing authorisation...
The European Medicines Agency's Committee for Medicinal Products for Human Use (...
An inline density measurement system enables real-time, waste-free granule monit...
EMA's CHMP has recommended the approval of CStone's sugemalimab for the first-li...
The 2024 ASCO Annual Meeting kicks off today, showcasing the latest research in ...
The CHMP has given a positive recommendation to Dupixent for COPD while the FDA ...
The EMA’s CHMP gave a positive opinion for Abbvie’s Skyrizi as the company bolst...
Global drug supply chains could be further disrupted as foreign pharma inspector...
The Swiss pharma ecosystem is on an upward trajectory after a tough economic yea...
Midland Pharmaceuticals has launched to focus on the development of a therapeuti...
While commercial uptake may be difficult for ivonescimab, a positive regulatory ...
